RAPP (RAPP) Stock Price & Analysis
RAPP (RAPP) rose 0.00% to USD 40.68 as of July 25, 2026 at 03:50 UTC, according to Nexqual real-time market data.
RAPP last closed at USD 40.68; the session ranged USD 40.25–41.81 on volume of 248,236 shares. Market capitalization is —, with a 52-week range of USD 13.62–44.28 (NGM). Source: Nexqual, July 25, 2026 at 03:50 UTC.
Key Statistics (as of July 25, 2026 at 03:50 UTC)
| Price | USD 40.68 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 40.68 |
| Open | USD 40.68 |
| Day Range | USD 40.25 – 41.81 |
| 52-Week Range | USD 13.62 – 44.28 |
| Volume | 248,236 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (RAPP)
Nexqual's technical model rates RAPP "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:50 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 52.91 (neutral) |
| vs SMA50 | Above (USD 38.75) |
| MACD | 0.78 (positive) |
From RAPP's Latest SEC 10-K Filing (filed 2026-03-10)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBX | MBX Biosciences, Inc. | USD 62 | ▲ 6.35% |
| MLYS | Mineralys Therapeutics, Inc. | USD 26.71 | ▼ 1.11% |
| BCAX | Bicara Therapeutics Inc. | USD 27.02 | ▼ 3.36% |
| ALMS | Alumis Inc. | USD 28 | ▼ 2.81% |
| AVBP | ArriVent BioPharma, Inc. | USD 31.73 | ▲ 4.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:50 UTC. This page is informational and not investment advice.